In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease

ABSTRACT: Objective: Perfluorohexyloctane (PFHO) MIEBOTM, formerly (NOV03) is a single component, water-free eye drop approved by the Food and Drug Administration in the United States for the treatment of dry eye disease. We evaluated the in vitro inhibitory effect of PFHO on the evaporation rate (...

Full description

Bibliographic Details
Main Authors: Jason Vittitow, Ph.D., Robert Kissling, M.D., Heleen DeCory, Ph.D., Douglas Borchman, Ph.D.
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Current Therapeutic Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0011393X23000139